
In pursuit of innovation to solve healthcare’s most important challenges
We are a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges.
Our mission
Our mission is to detect cancer early, when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, safe, and effective technologies that can transform cancer care.
Leadership

Bob Ragusa
Chief Executive Officer

Joshua Ofman, MD, MSHS
President

Sir Harpal Kumar
President, Biopharma Business & Europe

Aaron Freidin
Chief Financial Officer

Andy Partridge
Chief Commercial Officer

Julie Currie
Chief People Officer

Jeffrey Venstrom, MD
Senior Vice President of Medical Affairs and Chief Medical Officer

Amoolya Singh, PhD
Senior Vice President of Research and Chief Scientific Officer

Paul Ciccolella
Senior Vice President, Global Development and Operations

Satnam Alag, PhD
Senior Vice President, Software Engineering and Chief Security Officer

Abram Barth JD, MPH
General Counsel
Advisory Board

Otis Brawley, MD
Sidney Kimmel Comprehensive Cancer Center, School of Medicine Department of Epidemiology, Bloomberg School of Public Health Johns Hopkins University

Brian Druker, MD
Director, Knight Cancer Institute at Oregon Health & Science University JELD-WEN Chair of Leukemia Research

Dana Goldman, PhD
Interim Dean, USC Sol Price School of Public Policy Leonard D. Schaeffer Chair and Distinguished Professor of Pharmacy, Public Policy, and Economics, USC

Aashima Gupta, MS
Director, Global Healthcare Solutions, Google Cloud

Mark McClellan, MD, PhD
Robert J. Margolis Professor of Business, Medicine, and Policy Director of the Duke-Margolis Center for Health Policy at Duke University

Azra Raza, MD
Chan Soon-Shiong Professor of Medicine Director of the MDS Center at Columbia University, New York

Peter Sasieni, PhD
Academic Director of King’s Clinical Trials Unit, Kings College London

Charles Swanton, FRCP BSc PhD
The Francis Crick Institute

Elias Zerhouni, MD
Professor Emeritus, Johns Hopkins University